참고문헌
- Chen AP, Setser A, Anadkat MJ, et al (2012). Grading dermatologic adverse events of cancer treatments: the Common terminology criteria for adverse events version 4. 0. J Am Acad Dermatol, 67, 1025-39. https://doi.org/10.1016/j.jaad.2012.02.010
- Chumworathayi B (2013). Personalized cancer treatment for ovarian cancer. Asian Pac J Cancer Prev, 14, 1661-4. https://doi.org/10.7314/APJCP.2013.14.3.1661
- Ding Z-Y, Zhou L, Liu Y-M, et al (2013). Safety and efficacy of paclitaxel liposome for elderly patients with advanced non-small cell lung cancer: A multi-center prospective study. Thoracic Cancer, 4, 14-9. https://doi.org/10.1111/j.1759-7714.2012.00134.x
- Hiss DC, Gabriels GA, Folb PI (2007). Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int, 7, 5. https://doi.org/10.1186/1475-2867-7-5
- Hockel M, Sclenger K, Hamm H, et al (1996). Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer, 77, 1918-33. https://doi.org/10.1002/(SICI)1097-0142(19960501)77:9<1918::AID-CNCR24>3.0.CO;2-1
- Kesarwala AH, Grover S, Rengan R (2013). Role of particle beam therapy in a trimodality approach to locally advanced non-small cell lung cancer. Thoracic Cancer, 4, 95-101. https://doi.org/10.1111/j.1759-7714.2012.00174.x
- Liebling M, Boyd M, Rubio E, et al (2013). Airway metastasis of small cell lung carcinoma: A rare presentation. Thoracic Cancer, 4, 461-4. https://doi.org/10.1111/1759-7714.12000
- Lund B, Hansen OP, Theilade K, et al (1994). Phase II study of gemcitabine (2', 2'-difluorodeoxycytidine) in previously treated ovarian cancer patients. J Natl Cancer Inst, 86, 1530-3. https://doi.org/10.1093/jnci/86.20.1530
- Martinez-Monge R, Cambeiro M (2005). New techniques in irradiation: clinical implications of perioperative high-dose rate brachytherapy. Ann Oncol, 16, 73-8.
- Nag S, DeHaan M, Scruggs G, et al (2006). Long-term followup of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys, 64, 736-44. https://doi.org/10.1016/j.ijrobp.2005.08.029
- Nam S-J, Oak C-H, Jang T-W, et al (2013). Successful treatment of a tracheal squamous cell carcinoma with a combination of cryoablation and photodynamic therapy. Thoracic Cancer, 4, 191-4. https://doi.org/10.1111/j.1759-7714.2012.00126.x
- Nurwidya F, Takahashi F, Takahashi K (2012). Meeting report: Current cancer perspectives from the 9th Annual Meeting of the Japanese Society of Medical Oncology. Thoracic Cancer, 3, 94-7. https://doi.org/10.1111/j.1759-7714.2011.00076.x
-
Peng S, Yang QX, Zhang T, et al (2014). Lobaplatin-TACE combined with radioactive
$^{125}I$ seed implantation for treatment of primary hepatocellular carcinoma. Asian Pac J Cancer Prev, 15, 5155-60. https://doi.org/10.7314/APJCP.2014.15.13.5155 - Pitakkarnkul S, Tangjitgamol S, Srijaipracharoen S, et al (2013). Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand. Asian Pac J Cancer Prev, 14, 2421-7. https://doi.org/10.7314/APJCP.2013.14.4.2421
- Rogers BE, Rosenfeld ME, Khazaeli MB, et al (1997). Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J Nucl Med, 38, 1221-9.
- Scarabelli C, Gallo A, Carbone A (2001). Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol, 83, 504-12. https://doi.org/10.1006/gyno.2001.6404
- Schwarz SB, Thon N, Nikolajek K, et al (2012). Iodine-125 brachytherapy for brain tumours--a review. Radiat Oncol, 7, 30. https://doi.org/10.1186/1748-717X-7-30
- Shapiro JD, Millward MJ, Rischin D, et al (1996). Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel. Gynecol Oncol, 63, 89-93. https://doi.org/10.1006/gyno.1996.0284
- Sohaib A (2012). RECIST rules. Cancer Imaging, 12, 345-6. https://doi.org/10.1102/1470-7330.2012.9011
- Su A, Zhang J, Pan ZH, et al (2013). Salvage therapy of gemcitabine plus endostar significantly improves progression-free survival (PFS) with platinum-resistant recurrent epithelial ovarian cancer. Asian Pac J Cancer Prev, 14, 1841-6. https://doi.org/10.7314/APJCP.2013.14.3.1841
- Trombetta MG, Colonias A, Makishi D, et al (2008). Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung. Brachytherapy, 7, 50-4. https://doi.org/10.1016/j.brachy.2007.11.003
피인용 문헌
- Radiofrequency ablation and percutaneous permanent iodine-125 implantation as salvage therapy for giant recurrent sclerosing epithelioid fibrosarcoma of the chest wall: A case report pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3020
- Permanent Iodine-125 Seed Implantation for the Treatment of Nonresectable Retroperitoneal Malignant Tumors vol.18, pp.1533-0338, 2019, https://doi.org/10.1177/1533033819825845